1. Home
  2. HOVR vs ICCC Comparison

HOVR vs ICCC Comparison

Compare HOVR & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New Horizon Aircraft Ltd.

HOVR

New Horizon Aircraft Ltd.

HOLD

Current Price

$2.22

Market Cap

80.6M

Sector

Finance

ML Signal

HOLD

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

HOLD

Current Price

$9.58

Market Cap

75.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOVR
ICCC
Founded
2013
1982
Country
Canada
United States
Employees
30
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
80.6M
75.8M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
HOVR
ICCC
Price
$2.22
$9.58
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$10.33
N/A
AVG Volume (30 Days)
3.3M
19.6K
Earning Date
04-14-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
53.85
EPS
N/A
0.21
Revenue
N/A
$26,493,169.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$44.71
Revenue Growth
N/A
51.64
52 Week Low
$1.16
$4.52
52 Week High
$4.18
$10.75

Technical Indicators

Market Signals
Indicator
HOVR
ICCC
Relative Strength Index (RSI) 46.82 47.96
Support Level $2.06 $9.29
Resistance Level $2.56 $10.75
Average True Range (ATR) 0.20 0.38
MACD -0.05 -0.14
Stochastic Oscillator 19.48 6.78

Price Performance

Historical Comparison
HOVR
ICCC

About HOVR New Horizon Aircraft Ltd.

New Horizon Aircraft Ltd is an aerospace Original Equipment Manufacturer that is designing and building a next-generation hybrid electric vertical take-off and landing aircraft for the regional air mobility market. Its aircraft will offer a more efficient way to move people and goods at a regional scale, help to connect remote communities, and advance its ability to deal with an increasing number of climate-related natural disasters such as wildfires, floods, and droughts. The company aims to deliver a hybrid electric 7-seat aircraft, called the Cavorite X7, that can take off and land vertically like and helicopter.

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

Share on Social Networks: